2-Thiopheneethylamine CAS 30433-91-1 Purity >99.0% (GC) Clopidogrel Hydrogen Sulfate Intermediate Factory

Short Description:

Chemical Name: 2-Thiopheneethylamine

CAS: 30433-91-1

Purity: >99.0% (GC)

Appearance: Colorless or Slight Yellowish Transparent Liquid

Clopidogrel Hydrogen Sulfate Intermediate (CAS 135046-48-9)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply, High Purity, Commercial Production
Chemical Name: 2-Thiopheneethylamine CAS: 30433-91-1

Chemical Properties:

Chemical Name	2-Thiopheneethylamine
Synonyms	Thiophene-2-Ethylamine; 2-(2-Aminoethyl)thiophene; 2-Thiophene Ethylamine; 2-(Thiophen-2-yl)ethanamine; 2-(2-Thienyl)ethylamine
CAS Number	30433-91-1
CAT Number	RF-PI1006
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C6H9NS
Molecular Weight	127.21
Boiling Point	200.0~201.0℃/750 mmHg (lit.)
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Colorless or Slight Yellowish Transparent Liquid
Purity / Analysis Method	>99.0% (GC)
Moisture (K.F)	≤0.50%
Refractive Index	n20/D 1.549~1.551
Specific Gravity (20/20℃)	1.088~1.092
Single Impurity	≤0.50%
Total Impurities	<1.0%
Test Standard	Enterprise Standard
Usage	Pharmaceutical Intermediates

Package & Storage:

Package: Bottle, 25kg/Barrel, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

FAQ:

Application:

2-Thiopheneethylamine (CAS: 30433-91-1) is used as an intermediate of Clopidogrel Hydrogen Sulfate (CAS: 135046-48-9). Clopidogrel is useful for the preventativemanagement of secondary ischemic events, including myocardialinfarction, stroke, and vascular deaths. It may beclassified as a thienopyridine because of its heterocyclicsystem. Several agents possessing this system have beenevaluated as potential antithrombotic agents. These agentshave a unique mechanism, in that they inhibit the purinergicreceptor located on platelets. Normally, nucleotides act asagonists on these receptors, which include the P2Y type. Two P2Y receptor subtypes (P2Y1 and P2Y2) found onplatelets, when stimulated by adenosine diphosphate (ADP),cause platelet aggregation.